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 Abstract 
  Background:  This study explores factors associated with depression in Alzheimer’s disease (AD) 
compared with mild cognitive impairment (MCI) and other dementia disorders.   Method:   In a 
prospective study we included 195 patients: 31 with MCI, 112 with AD and 52 with other demen-
tias.  Results:  According to the ICD-10 and the DSM-IV criteria, 88 (44.1%) and 59 (30.3%), respec-
tively, had a depressive disorder. An adjusted multiple regression analysis showed that previous 
depression (p   !   0.05) was significantly associated with depression in AD patients. Severity of 
dementia (p   !   0.05) was significantly associated with a depressive disorder in a group of pa-
tients with frontotemporal dementia, vascular dementia, or dementia due to Lewy Body disease 
or Parkinson’s disease.  Conclusion:  We found different factors associated with a depressive dis-
order in AD compared to those found for other dementia disorders. 
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 Introduction 
 Depression is highly prevalent among persons with dementia of any degree and any type, 
and even in patients with mild cognitive impairment (MCI). Various studies and review pa-
pers report prevalence rates of 20–25% for a depressive disorder, and 40 or even 50% if pa-
tients with minor depression or ‘significant symptoms of depression’ are included   [ 1–3]  . 
Some studies report a higher prevalence rate in patients in an early phase of dementia   [4, 5]  , 
whereas other studies report the opposite, i.e. a higher prevalence rate in severe dementia 
  [6–8]  . However, a recently published review paper reported that depression, both at disorder 
and symptom level was equally often observed whatever the severity of the dementia   [1]  . 
Thus, depression in patients with dementia and MCI most probably is a heterogeneous con-
dition that can be caused by psychological as well as by various biological factors.
    In an early stage of dementia or in MCI, depression could be due to the patient’s aware-
ness of the disease and insight into impaired cognitive function   [9]  . In this context it is pos-
sible that depression in dementia could also be linked to stress, but this hypothesis has nev-
er been confirmed   [10, 11]  .
    Depression in a late stage of dementia, by contrast, could be due to specific structural or 
biochemical changes in the brain   [12]  . The evidence for an association between serotonin 
depletion and depression in patients with dementia is poor. Post-mortem studies are few, and 
they report contradictory results, include only a small number of patients and are not con-
clusive   [13–15]  . Studies with functional neuroimaging demonstrate, however, serotonergic 
dysfunction both in patients with Alzheimer’s disease (AD) and frontotemporal lobar degen-
eration, also called frontotemporal dementia (FTD), but the location of the serotonergic dys-
function in the brain varies in different studies, and therefore it is difficult to draw signifi-
cant conclusions   [16]  . Depression in dementia has also been found to be associated with de-
creased blood flow in the prefrontal areas, the superior frontal and anterior cingulate region, 
as demonstrated in two studies using the positron emission tomography technique   [17, 18]  .
  Another possible association between depression and dementia could be due to vascular 
changes of the brain as depression is more often seen in vascular dementia (VaD) than in AD 
  [19, 20]  . In addition, several studies have shown a significant relationship between vascular 
risk factors and depression in the elderly both with and without dementia   [10, 21]  . Depres-
sion could also be caused by specific structural damage, for example to the amygdala  [22] , in 
the frontal cortex or in the frontostriatal areas. As assessed by MRI, white matter hyperin-
tensities in the frontal and right parietal lobe are correlated with depression in AD   [23–25]  , 
but depression is even more prevalent in dementias where frontostriatal changes are com-
mon such as in FTD, dementia with Lewy bodies (DLB), Parkinson’s disease dementia (PDD) 
and VaD   [20, 26]  .
  A further explanation could be that genetic factors could increase the risk for depression 
in the course of a brain disorder, like AD, stroke or Parkinson’s disease. In a study by 
Holmes et al.   [27]  , polymorphism of the receptor genes 5-HT2A and 5-HT2C were found to 
increase the risk of major depression in AD patients. A twelve-fold risk was found when in-
dividuals with homozygote 5-HT2C Ser allele were compared with individuals with the 
5HT-2S Cys allele. In both AD and Parkinson’s disease, alterations of the serotonin trans-
porter gene were associated with depression, but not in VaD   [28–30]  . To sum up: it might be 
that a combination of awareness of and insight into cognitive impairment (a psychological 
factor), and biological factors together can increase the risk for depression. However, one has 
to bear in mind that significant risk factors for late depression in general, such as female gen-
der and functional impairment   [31]  , could also be important in cognitively impaired pa-
tients.21
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    Many elderly persons have depressive symptoms. In population-based studies it is re-
ported that 11–30% have symptoms of depression, but this does not mean all these persons 
have a depressive disorder   [32]  . The same is found in clinical studies, where the prevalence 
rates are even higher   [2]  .
    Thus, the aim of the present study was to explore factors associated with a depressive 
disorder in patients with different types of dementia, especially to compare patients with AD 
and dementia disorders with a high probability of having suffered damage in the fronto-
striatal cortical circuit.
  M e t h o d s  
 Study  Subjects 
 We conducted the study between October 2008 and August 2009. The study population 
comprised 195 inpatients older than 60 years, with MCI and dementia of any type and of 
various degrees. They were recruited from two hospital departments of geriatric psychiatry 
(n = 94), one department of geriatric medicine (n = 10) and five nursing homes (n = 91). The 
patients from hospital departments of geriatric psychiatry were admitted for assessment for 
behavioral and psychiatric symptoms of dementia, and they were consecutively recruited 
for the study, whereas the patients in nursing homes and in the department of geriatrics 
were asked to participate without using any selection criteria. All patients had been staying 
in the institution for at least 4 weeks and many of the patients of the hospital sample had 
been admitted from nursing home care and were re-admitted to nursing home care after 
the assessments had been made in the hospital. The only exclusion criteria were patients 
with bipolar depression or manic episodes. A detailed description of the sample is given 
elsewhere   [33] .
    Diagnostic Procedures for the Diagnosis of Depression and Dementia 
  The patients were interviewed by one of four senior geriatric psychiatrists, who had ac-
cess to the patients’ medical records. In cases of dementia of severe degree and/or aphasia, a 
nurse or a relative who knew the patient well was also interviewed. The psychiatrists diag-
nosed depression according to the research criteria of ICD-10 and DSM-IV (major depres-
sion). A template with a list of all the symptoms required for the two diagnoses of depression 
was used during the interview. The four psychiatrists met to ensure that the diagnostic pro-
cedures were followed in the same way.
  The diagnosis of dementia was made after a comprehensive clinical examination accord-
ing to the ICD-10 criteria for research. We used the ICD-10 to diagnose AD, VaD and PDD, 
whereas the Manchester–Lund criteria were used for the diagnosis of FTD and the revised 
McKeith criteria for the diagnosis of DLB   [34, 35]  . MCI was diagnosed according to the cri-
teria by Winblad et al.  [36] . The diagnostic assessment included the patient’s medical history 
told by him-/herself and an informant, physical and mental examinations, laboratory tests, 
neuropsychological tests, and usually an image of the brain. In most cases, a dementia diag-
nostic investigation had been performed years before the present study and we used both the 
information from the patients’ records and the information from the new clinical examina-
tion to make the dementia diagnosis.
  A s s e s s m e n t   S c a l e s  
  The patients were assessed by seven trained research nurses, who applied three assess-
ment scales. Prior to the present study they had received a 1-day training course and they 
could contact the project leader during the study if necessary. The Cornell Scale for Depres-22
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sion in Dementia was used to rate depressive symptoms and a standard procedure was fol-
lowed: a nurse filled in the scale after an interview with the patient’s primary caregiver and 
a brief interview with the patient. The scale consists of 19 items. Each item is rated from 0 
(no symptom) to 2 (severe symptom) (range = 0–38). The scale allows for the entry, ‘not pos-
sible to evaluate’   [37]  . The patient’s ability to perform the basic activities of daily living was 
measured by interviewing the patients’ primary caregivers by means of the Self Maintenance 
Scale   [38]  . It consists of 6 items and the score can vary between 6 and 30; a higher score de-
notes greater impairment.
    Assessment of cognition and stage of dementia was done by the psychiatrists who made 
the diagnoses by means of the Mini Mental State Examination (MMSE)  [39]  and the Clinical 
Dementia Rating scale (CDR)   [40]  . The score on MMSE varies between 0 and 30; a higher 
score denotes better cognition. A score on CDR below 1 indicates no dementia, 1 indicates 
mild and 2 moderate dementia, whereas 3 denotes a severe degree of dementia. The CDR can 
also be used as a continuous scale by adding the individual item scores into a sum score. In 
that case, the minimum score is 0 and the maximum 18. No cutoff point is used with this 
method, but statistical analysis using the continuous CDR might have more statistical pow-
er. The two scoring systems correlate highly, about 0.9   [41, 42]  .
  The patients’ age, gender, previous and present medical and psychiatric history and their 
use of any drugs were collected from the patients’ records. In addition and according to the 
case record form, the psychiatrists specifically interviewed a caregiver if the patients had suf-
fered a depressive or any other psychiatric disorder earlier in life. Chronic and present phys-
ical disorders were organized in 10 groups of disorders, e.g. cardiovascular disorders, endo-
crine disorders, neoplasm, disorders in the eyes, ears, genitourinary organs, respiratory or-
gans, digestive organs and also musculoskeletal disorders, and others.
  S t a t i s t i c s  
  Statistical analyses were performed with SPSS version 17. For data on continuous scales 
we used the independent t test to examine differences between groups (depressed vs. non-
depressed) if the data was normally distributed, and the Mann–Whitney U test was used for 
non-normally distributed data. For categorical data, differences between groups were tested 
with the     2   test in large groups and the Fisher exact test for smaller samples. Thereafter, we 
performed multiple logistic regression analyses (enter method) with a diagnosis of depres-
sion according to ICD-10 as the dependent variable. Variables with a p value below 0.2 in the 
simple comparative analyses in addition to age and gender were used as independent vari-
ables. We repeated the analyses with the DSM-IV diagnosis of depression as the dependent 
variable. 
    In the analyses we divided the 195 patients into four diagnostic groups: MCI, AD, un-
specified dementia and a mixed diagnostic group consisting of patients with VaD, FTD, or 
DLB/PDD. The composition of the latter group was based on the assumption that changes 
in the frontostriatal circuit are associated with depression and that the reason for this might 
be structural brain changes. Due to a low number of patients, we decided to leave this as a 
mixed group.
  E t h i c s  
  The study was approved by the Regional Ethics Committee, the Data Inspectorate and 
the Directorate for Health and Social Affairs. The patients gave their informed consent in 
writing. In cases where the patients had reduced or no capacity to give consent, the next of 
kin gave their informed consent in writing.23
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  R e s u l t s  
  Of the 195 patients, 31 (15.9%) had MCI, 112 (57.5%) had AD, 20 (10.3%) had VaD, 6 
(3.1%) had DLB or PDD, 5 (2.6%) had FTD, and 21 (10.8%) had atypical or unspecified de-
mentia.   Table 1   shows the patient characteristics for the 195 patients, including the use of 
antidepressants. Among the 195 patients with MCI or dementia, 86 (44.1%) had depression 
according to ICD-10: 31 (15.9%) mild, 37 (19%) moderate, and 18 (9.2%) severe; and 59 (30.3%) 
had major depression according to DSM-IV criteria. Among the 112 patients with AD, 53 
(47.3%) had depression according to ICD-10: 19 (17%) mild, 24 (21.4%) moderate, and 10 
(8.9%) severe; and 39 (34.8%) had major depression according to DSM-IV criteria. All pa-
tients with a DSM-IV major depression were also diagnosed as depressed using the ICD-10 
criteria.   Table 2   shows the prevalence rate of depression according to MCI and dementia di-
agnoses. 
   Table 3   shows differences between the depressed and non-depressed groups in each of 
the four diagnostic groups using the ICD-10 criteria for the diagnosis of depression. We also 
tested differences for the presence of the 10 most prevalent physical disorders, but none of 
these differed between the depressed and non-depressed patients in the four groups (data not 
shown). We also tested for differences between the depressed and non-depressed subjects for 
Women 132 (67.7)
Age, years 8287.8
Married 72 (36.9)
MMSE score  12.988.8
CDR
0.5 22 (11.3)
1.0 38 (19.5)
2.0 53 (27.2)
3.0 81 (41.5)
Previous depression 51 (26.2)
Cornell score  9.085.5
PADL score  16.485.9
Physical disordersa 2.881.7
ICD-10 depressive disorder 86 (44.1)
Use of antidepressants, non-depressed 37/109 (33.9) 
Use of antidepressants, depressed 61/86 (70.9)
F  igures are n (%) or means 8 SD. 
a Physical disorders were grouped into 10 subgroups, see text.
Table 1. C  haracteristics of the 
195 patients
Table 2. P  revalence rates of a depressive disorder for the 4 diagnostic groups according to the ICD-10 cri-
teria and DSM-IV criteria for major depression
Diagnosis ICD-10 criteria, n (%) DSM-IV criteria, n (%)
MCI (n = 31) 9 (29.0) 5 (16.1)
AD (n = 112) 53 (47.3) 39 (34.8)
Other defined dementias (n = 31)a 16 (52.0) 11 (35.5)
Mixed or unspecified dementia (n = 21) 8 (38.1) 4 (19.0)
a  VaD = 20, DLB/PDD = 6, FTD = 5.24
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the whole group of the mentally impaired 195 patients, regardless of diagnoses, and found 
that younger age of patients (    2   test, p = 0.04), a history of depression (    2   test, p   !   0.001) and 
the presence of a genitourinary disorder (    2   test, p = 0.04) were associated with depression. 
The results using the DSM-IV diagnosis of depression did not differ from this result (not 
shown). 
   Table 4   shows the results of 10 multiple logistic regression analyses. For all patients (n = 
195) both a history of depression and the severity of dementia was significantly associated 
with a depressive disorder according to ICD-10, and when using the DSM-IV criteria, young-
er age was also a significant factor. As can be observed in  table 4 , we found different risk fac-
Table 3. C  omparison of characteristics between patients with and without depression according to ICD-10
Characteristic AD 
(n = 112)
VaD/DLB/PDD/FTD 
(n = 31)
MCI 
(n = 31)
Unspecified dementia 
(  n = 21)
depressed
(n = 53)
non-de-
pressed
(n = 59)
p value 
t test or 2
depressed
(n = 16)
non-de-
pressed
(n = 15)
p value 
t test or 
Fisher 
depressed
(n = 9)
non-de-
pressed
(n = 22)
p value 
t test or 
Fisher
depres sed
(n = 8)
non-de-
pressed
(n = 13)
p value  
t test or 
Fisher
Age, years 82.088.1 83.987.7 0.20 80.0887.3 79.988.6 0.95 77.686.8 79.987.5 0.42 84.387.1 83.785.9 0.85
Women 40 (75.5) 37 (62.7) 0.15 7 (43.8) 8 (53.3) 0.58 6 (66.7) 17 (77.3) 0.66 7 (87.5) 10 (76.9) 1.00
Married 15 (28.3) 20 (33.9) 0.52 7 (43.8) 6 (40) 0.83 6 (66.7) 9 (40.9) 0.25 6 (75) 3 (23.1) 0.03
Previous depression 18 (34) 9 (15.3) 0.02 4 (25) 1 (6.7) 0.17 4 (44.4) 8 (36.4) 0.70 5 (62.5) 2 (15.4) 0.05
CDR sum 13.584.1 13.583.9 1.00 12.884.1 9.084.5 0.03 5.8842.0 4.783.7 0.52 11.387.0 11.084.8 0.91
PSMS score 16.785.5 17.785.1 0.31 19.185.5 15.885.5 0.12 12.385.3 11.084.0 0.48 15.388.5 17.887.3 0.47
Physical disorders 3.082.0 2.781.6 0.35 2.881.5 3.381.7 0.44 3.281.1 2.681.4 0.27 2.581.6 2.782.2 0.83
Figures are n (%) or means 8 SD. PSMS = Physical Self Maintenance Scale.
Table 4. M  ultiple logistic regression of correlates of depression according to ICD-10 and DSM-IV among patients with MCI 
and dementia
ICD-10 criteria D  SM-IV criteria
B Wald OR (95% CI) p value B Wald  OR (95% CI) p value
All (n = 195)
Previous depression 1.09 9.16 3.0 (1.5–6.1) 0.002 1.26 10.81 3.5 (1.7–7.5) 0.001
CDR score 0.76 5.9 1.1 (1.0–1.15) 0.02 0.11 8.88 1.1 (1.03–1.2) 0.03
Age <85 versus ≥85 0.30 0.93 0.74 (0.4–1.4) 0.34 0.91 6.2 0.41 (0.2–0.8) 0.01
MCI (n = 31)
Previous depression 2.22 4.17 9.2 (1.1–77.7) 0.04 2.39 3.02 10.9 (0.7–161) 0.08
CDR score 0.01 0.01 0.99 (0.8–1.2) 0.92 0.00 0.00 0.99 (0.8–1.3) 0.99
AD (n = 112)
Previous depression 1.02 4.47 2.8 (1.1–7.1) 0.034 1.42 8.07 4.1 (1.6–10.9) 0.005
CDR score 0.02 0.16 1.0 (0.9–1.1) 0.69 0.41 0.53 1.04 (0.9–1.7) 0.46
Age <85 versus ≥85 0.43 1.15 0.65 (0.29–1.4) 0.28 –1.0 4.93 0.37 (0.15–0.9) 0.03
VaD/FTD/DLB PDD (n = 31)
Previous depression 1.79 1.70 6.0 (0.4–89.0) 0.20 1.32 1.18 3.7 (0.3–41) 0.28
CDR score 0.21 4.38 1.2 (1.01–1.5) 0.04 0.25 4.81 1.3 (1.03–1.6) 0.03
Unspecified dementia (n = 21)
Previous depression 0.90 0.94 2.5 (0.4–15.1) 0.33 1.0 0.93 4.3 (0.22–85) 0.33
CDR score 0.63 0.25 1.1 (0.8–1.4) 0.62 0.34 0.51 1.03 (0.8–1.4) 0.82
Hos  mer–Lemeshow test above 0.05 in all models.25
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tor profiles for depression in patients with AD and the mixed group with the diagnoses of 
VaD/FTD/DLB/PDD, both by the use of ICD-10 and DSM-IV criteria. A history of depres-
sion was significantly associated with a depressive disorder in AD, whereas the severity of 
dementia as measured by the CDR was not significant. For the group of patients with VaD/
FTD/DLB/PDD the results were the other way round. The results for the MCI patients were 
similar to the AD patients, whereas for the patients with atypical or unspecified dementia, 
we found no factor associated with a depressive disorder. Gender or any physical disorders 
or functional impairment were not statistically significant in any of the models.
  Discussion 
  The two main findings of the present study were that a history of (previous) depression 
was the strongest factor associated with a depressive disorder in the AD patients regardless 
of whether we used the ICD-10 criteria for depression, which is less strict, or the DSM-IV 
criteria. The strongest factor associated with a depressive disorder in the group of patients 
with possible damage to the frontostriatal circuit was severity of dementia. These results 
could indicate that psychological factors such as awareness and insight into their own cogni-
tive impairment is among the most important risk factors for a depressive disorder in AD 
patients. However, as we have no information on the patients’ awareness, we cannot know 
for sure. One could argue that this interpretation is partly supported by the fact that a his-
tory of depression was also significantly associated with a depressive disorder among the 
MCI patients (using the ICD-10 criteria for depression). We cannot claim that genetic factors 
play a role, as we have not done any genetic testing. However, it is possible that individuals 
with a genetic predisposition for depression are more at risk of developing depression in 
stressful situations throughout life   [11, 43]  . To suffer from MCI and dementia is without 
doubt such a stressful event. 
    Using the DSM-IV criteria for a depressive disorder, younger age was significantly as-
sociated with a depressive disorder, a finding that is supported by several other studies show-
ing that depression is more common among younger than among elderly patients with de-
mentia   [44] .
  Severity of dementia was associated with depressive disorder in the mixed group of VaD/
FTD/DLB/PDD patients. We suggest that psychological factors cannot explain this associa-
tion, because a history of depression was not a significant factor in these patients. On the 
contrary, biological factors are probably the explanation. We hypothesize that structural 
changes in the frontostriatal areas might be the main cause for depression in this group. A 
change in the frontostriatal circuit has been shown to be associated with depression in other 
studies as well   [24]  .
    As seen in   table 3  , many of the patients without a depressive disorder received antide-
pressants and some of those with a depressive disorder did not receive drug treatment. Could 
the prescription and use of antidepressants have influenced the results? Could it be that some 
of the users of antidepressants had recently recovered from depression? We do not know, and 
the question remains open. The explanation for the widespread use of antidepressants among 
Norwegian patients with dementia may be a result of the custom among doctors to prescribe 
antidepressants for the treatment of neuropsychiatric symptoms. Several large studies have 
shown that 35–40% of all nursing home patients receive antidepressants   [45, 46]  .
    The study has limitations. First, we included patients from three sources, which could 
have biased the results. A typical nursing home patient may be different from a patient ad-
mitted to a hospital for assessment and treatment. However, most of the in-hospital patients 
either came from a nursing home or were admitted to a nursing home after treatment. We 26
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do not have the exact number, but in another paper we have shown that they do not differ. 
Second, although the four psychiatrists were specially trained in geriatric psychiatry they 
could have diagnosed depression differently. One could argue that at least two psychiatrists 
should have diagnosed all the patients. For practical reasons this was not possible, but to en-
sure that the psychiatrists used the same diagnostic procedure a common template was used, 
and the psychiatrists discussed the diagnostic process during the study. Third, the etiologi-
cal diagnosis of dementia is difficult to make. We used standard research criteria for the dif-
ferent diagnoses and compared previous and present findings from dementia work-ups but 
still it could be difficult to obtain the correct dementia diagnosis. An fourth limitation is the 
small number of patients, which could influence the statistical analyses. The logistic regres-
sion models included a small number of patients in some of the diagnostic groups which re-
sulted in large 95% confidence intervals for the odds ratios. However, the Hosmer–Leme-
show test was above 0.05 for all analyses, supporting the models. But, the confidence inter-
vals were narrow regarding the results of the main findings, the analyses of the factors 
significantly associated with a depressive disorder in the AD and the VaD/FTD/DLB/PDD 
patients (  table 4 ).
    We conclude that a history of depression was the strongest significant factor associated 
with a depressive disorder in AD and that severity of dementia was the strongest factor asso-
ciated with depression in the group of patients with either a diagnosis of VaD, FTD, or DLB. 
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